Proquility Private Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,890
Closed -$753K 84
2024
Q4
$753K Sell
2,890
-456
-14% -$135K 0.24% 72
2024
Q3
$1.08M Sell
3,346
-22
-0.7% -$7.2K 0.35% 70
2024
Q2
$1.05M Buy
3,368
+464
+16% +$136K 0.36% 68
2024
Q1
$826K Buy
2,904
+9
+0.3% +$2.63K 0.28% 76
2023
Q4
$834K Sell
2,895
-711
-20% -$194K 0.32% 71
2023
Q3
$969K Sell
3,606
-19
-0.5% -$4.74K 0.4% 65
2023
Q2
$805K Buy
3,625
+3
+0.1% +$696 0.31% 74
2023
Q1
$876K Sell
3,622
-246
-6% -$60.4K 0.35% 72
2022
Q4
$1.02M Buy
3,868
+37
+1% +$9.92K 0.42% 63
2022
Q3
$863K Sell
3,831
-24
-0.6% -$5.82K 0.4% 64
2022
Q2
$938K Sell
3,855
-18
-0.5% -$4.41K 0.4% 68
2022
Q1
$948K Buy
3,873
+566
+17% +$130K 0.4% 63
2021
Q4
$757K Sell
3,307
-245
-7% -$51.7K 0.27% 79
2021
Q3
$755K Buy
3,552
+110
+3% +$25.3K 0.29% 72
2021
Q2
$839K Buy
3,442
+62
+2% +$15.3K 0.32% 72
2021
Q1
$841K Buy
3,380
+1,070
+46% +$255K 0.34% 68
2020
Q4
$531K Buy
+2,310
New +$533K 0.24% 71

Other funds holding AMGN

Proquility Private Wealth Partners's AMGN Position: Q1 2025 in Review

Proquility Private Wealth Partners sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,890 shares — an estimated $753K sold.

Proquility Private Wealth Partners first reported a position in AMGN in Q4 2020 and held it in 17 quarters. The position peaked at $1.08M in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Proquility Private Wealth Partners reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Proquility Private Wealth Partners sold 2,890 Amgen shares in Q1 2025, an estimated $753K.
  • Proquility Private Wealth Partners first reported a position in Amgen in Q4 2020 and held it in 17 quarters.
  • Proquility Private Wealth Partners's Amgen position peaked at $1.08M in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Proquility Private Wealth Partners's 13F filing for Q1 2025, filed 15 May 2025.